Under construction – not a live service
Sign in
Taking people in ItalyNo phase

Using machine learning to tell two eosinophil-related diseases apart: EGPA and hypereosinophilic syndrome

Studies patient data with computer methods to tell EGPA from hypereosinophilic syndrome.

Plain-language title generated from the registry record
Registry title: The Use of Machine Learning Techniques for the Differential Diagnosis Between Eosinophilic Granulomatosis With Polyangiitis and Hypereosinophilic Syndrome

Key facts

Where
Pavia, ItalySee the site

Where in Italy

  • Fondazione IRCCS Policlinico San Matteo, SC ReumatologiaPavia, ItalyTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Fondazione IRCCS Policlinico San Matteo di Pavia
Trial code
NCT07275190
Record updated
10 December 2025
Original description
The purpose of this study is to collect clinical, laboratory, and instrumental data from patients with eosinophilic granulomatosis with polyangiitis or hypereosinophilic syndrome, which will then be analyzed using artificial intelligence techniques with the aim of identifying characteristics that differentiate the two diseases and can predict the response to the treatment plan.Read full original descriptionShow less

The Use of Machine Learning Techniques for the Differential Diagnosis Between Eosinophilic Granulomatosis With Polyangiitis and Hypereosinophilic Syndrome

The purpose of this study is to collect clinical, laboratory, and instrumental data from patients with eosinophilic granulomatosis with polyangiitis or hypereosinophilic syndrome, which will then be analyzed using artificial intelligence techniques with the aim of identifying characteristics that differentiate the two diseases and can predict the response to the treatment plan.

Inclusion: 18 years of age or over; A diagnosis of EGPA or HES; Willing and able to give informed written consent, or willing to give permission for a nominated friend or relative to provide written informed assent if they are unable to do so because of physical disabilities.

Exclusion: Lack of a confirmed diagnosis of EGPA or HES; Other causes of eosinophilia.

ClinicalTrials.gov NCT07275190